CONTAINMENT DEVICE FOR SITE-SPECIFIC DELIVERY OF A THERAPEUTIC MATERIAL AND METHODS OF USE

• US 20080103505A1
• Filed: 10/04/2007
• Published: 05/01/2008
• Est. Priority Date: 10/26/2006
• Status: Abandoned Application

• Current Assignee: William Cook Europe ApS (Cook Group Incorporated)
• Original Assignee: William Cook Europe ApS (Cook Group Incorporated)
• Inventors: Fransen, Hendrik Raoul Andre
• Application Number:
  US11/867,429
• Publication Number:
  US 20080103505A1
• Time in Patent Office: Days
• US Class Current: 606/92
• CPC Class Codes: A61B 17/7097 Stabilisers comprising fluid filler in an implant, e.g. balloon; devices for inserting or filling such implants disc prostheses made of inflatable chambers or pockets filled with fluid A61F2/441; replacing the nucleus pulposus A61F2002/444

Abstract

The present invention is directed to devices and methods for the controlled delivery of a therapeutic material into the treatment site to prevent unintentional migration of the therapeutic material from the treatment site. The devices include an expandable containment body made of a naturally-derived collagenous material and a delivery device to convey the containment body into a treatment location within a body. The invention is also directed to a method of treating a bone, an aneurysm, or arteriovenous malformations by providing the containment device.

Claims

1. A containment device for site-specific delivery of a therapeutic material without unintentional leakage into adjacent anatomy, comprising

a. an expandable containment body comprising a naturally-derived collagenous material;

and

b. a delivery device to convey the containment body into a treatment location within a body, the delivery device having a proximal delivery device end, a distal delivery device end, and at least one lumen extending between the proximal delivery device end and the distal delivery device end,

wherein the containment body is detachably attached to the distal end of the delivery device.

2. The device of claim 1, wherein the naturally-derived collagenous material is selected from the group consisting of submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, fascia lata, serosa, peritoneum or basement membrane layers, liver basement membrane, intestinal submucosa, small intestinal submucosa, stomach submucosa, urinary bladder submucosa, and uterine submucosa.

3. The device of claim 1, wherein the containment body is perforated.

4. The device of claim 1, wherein the containment body further comprises the therapeutic material.

5. The device of claim 4, wherein the therapeutic material is integrated with the containment body prior to conveying the containment body into a treatment location within a body.

6. The device of claim 1, wherein the therapeutic material is inserted following the delivery of the containment body.

7. The device of claim 1, further comprising a guide sheath.

8. The device of claim 7, wherein the delivery device is controllable from a proximal end of the guide sheath and movable between a first configuration for holding the expandable containment body in a radial compression having an unexpanded diameter, and a second configuration where the expandable containment body can assume an expanded diameter.

9. The device of claim 1, wherein the containment body further comprises an opening through which the therapeutic material may be inserted.

10. The device of claim 9, wherein the opening of the containment body is sealable.

11. The device of claim 1, wherein the therapeutic material is a bone cement.

12. The device of claim 1, wherein the therapeutic material is a biomaterial.

13. The device of claim 1, wherein the therapeutic material is an antibiotic, a growth factor, or a chemotherapeutic agent.

14. The device of claim 1, wherein the delivery device is a catheter.

15. A method of treating a bone, an aneurysm, or arteriovenous malformations, comprising providing the containment device of claim 1.

16. The method of claim 15, wherein the naturally-derived collagenous material is selected from the group consisting of submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, fascia lata, serosa, peritoneum or basement membrane layers, liver basement membrane, intestinal submucosa, small intestinal submucosa, stomach submucosa, urinary bladder submucosa, and uterine submucosa.

17. A containment device for site-specific delivery of a therapeutic material to a bony body without unintentional leakage into the adjacent anatomy, comprising:

a. an expandable containment body comprising a naturally-derived collagenous material; and

b. a delivery device to convey the containment body into an interior of the bony body through an opening in a bony body, the delivery device having a proximal delivery device end, a distal delivery device end, and at least one lumen extending between the proximal delivery device end and the distal delivery device end,

wherein the containment body is detachably attached to the distal end of the delivery device.

18. The device of claim 17, wherein the naturally-derived collagenous material is selected from the group consisting of submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, fascia lata, serosa, peritoneum or basement membrane layers, liver basement membrane, intestinal submucosa, small intestinal submucosa, stomach submucosa, urinary bladder submucosa, and uterine submucosa.

19. A containment device for site-specific delivery of a therapeutic material to a vertebral body without unintentional leakage into the adjacent anatomy, comprising

a. an expandable containment body comprising a naturally-derived collagenous material;

b. a delivery device to convey the containment body into an interior of the vertebral body, the delivery device having a proximal delivery device end, a distal delivery device end, and at least one lumen extending between the proximal delivery device end and the distal delivery device end,

wherein the containment body is detachably attached to the distal end of the delivery device.

20. The device of claim 19, wherein the naturally-derived collagenous material is selected from the group consisting of submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, fascia lata, serosa, peritoneum or basement membrane layers, liver basement membrane, intestinal submucosa, small intestinal submucosa, stomach submucosa, urinary bladder submucosa, and uterine submucosa.